Pharmacodynamic and Clinical Results from a Phase I/II Study of the HSP90 Inhibitor Onalespib in Combination with Abiraterone Acetate in Prostate Cancer
一项 HSP90 抑制剂 Onalespib 联合醋酸阿比特龙治疗前列腺癌的 I/II 期研究的药效学和临床结果
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-18-3212
Slovin, Susan; Hussain, Syed; Saad, Fred; Garcia, Jorge; Picus, Joel; Ferraldeschi, Roberta; Crespo, Mateus; Flohr, Penelope; Riisnaes, Ruth; Lin, Chihche; Keer, Harold; Oganesian, Aram; Workman, Paul; de Bono, Johann
